LA JOLLA PHARMACEUTICAL COMPANY Trademark

Trademark Overview

On Monday, June 14, 2004, a trademark application was filed for LA JOLLA PHARMACEUTICAL COMPANY with the United States Patent and Trademark Office. The USPTO has given the LA JOLLA PHARMACEUTICAL COMPANY trademark a serial number of 78434921. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 2, 2009. This trademark is owned by La Jolla Pharmaceutical Company. The LA JOLLA PHARMACEUTICAL COMPANY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of antibody-mediated diseases
la jolla pharmaceutical company

General Information

Serial Number78434921
Word MarkLA JOLLA PHARMACEUTICAL COMPANY
Filing DateMonday, June 14, 2004
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 2, 2009
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, November 8, 2005

Trademark Statements

Disclaimer with Predetermined Text"PHARMACEUTICAL COMPANY"
Goods and ServicesPharmaceutical preparations for the treatment of antibody-mediated diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, June 21, 2004
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLa Jolla Pharmaceutical Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameLa Jolla Pharmaceutical Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Monday, March 2, 2009ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, March 2, 2009ABANDONMENT - NO USE STATEMENT FILED
Thursday, July 17, 2008EXTENSION 5 GRANTED
Thursday, July 17, 2008EXTENSION 5 FILED
Thursday, July 17, 2008TEAS EXTENSION RECEIVED
Monday, January 7, 2008EXTENSION 4 GRANTED
Monday, January 7, 2008EXTENSION 4 FILED
Monday, January 7, 2008TEAS EXTENSION RECEIVED
Monday, July 30, 2007EXTENSION 3 GRANTED
Monday, July 30, 2007EXTENSION 3 FILED
Monday, July 30, 2007TEAS EXTENSION RECEIVED
Wednesday, January 24, 2007EXTENSION 2 GRANTED
Wednesday, January 24, 2007EXTENSION 2 FILED
Wednesday, January 24, 2007TEAS EXTENSION RECEIVED
Monday, July 24, 2006EXTENSION 1 GRANTED
Monday, July 24, 2006EXTENSION 1 FILED
Monday, July 24, 2006TEAS EXTENSION RECEIVED
Tuesday, January 31, 2006NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 8, 2005PUBLISHED FOR OPPOSITION
Wednesday, October 19, 2005NOTICE OF PUBLICATION
Friday, August 26, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, August 25, 2005ASSIGNED TO LIE
Tuesday, August 16, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 16, 2005TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 15, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 16, 2005TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 12, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 15, 2005PAPER RECEIVED
Friday, August 12, 2005FAX RECEIVED
Monday, August 1, 2005AMENDMENT FROM APPLICANT ENTERED
Wednesday, July 27, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 27, 2005PAPER RECEIVED
Monday, January 24, 2005EXAMINER'S AMENDMENT AND/OR PRIORITY ACTION MAILED
Monday, January 24, 2005EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Friday, January 14, 2005ASSIGNED TO EXAMINER
Monday, June 21, 2004NEW APPLICATION ENTERED IN TRAM

Related Keywords

company pharmaceutical jolla mediated diseases antibody treatment preparations